Democratising Personalisation in Health and Beauty

July 2021

Interest in personalised approaches to health and beauty has surged since COVID-19, as improvements in technology have been met by a more accepting public focused on health outcomes and demanding products that fit their unique goals. Personalisation is becoming a mainstream proposition, as the industry is able to build actionable, quality data more quickly and effectively through network effects and as larger, more established players enter the space through acquisition or investment.

USD 1,325
Request More Information

Key findings

Personalisation in health and beauty is on the cusp of mainstream interest

After years as a niche premium product, personalised health and beauty is closer than ever to extending its offer towards the mass marketplace by taking advantage of iterative improvements to technology and wider consumer willingness to engage with such products.

COVID-19 demands are pushing broader interest in personalisation

This broader consumer movement towards interest in personalisation derives from the demands brought about by COVID-19, especially around the centralising focus on health outcomes, lifestyles and nutrition. In this way, the COVID-19 era has provided the foundation for a more mainstream version of personalisation.

Transparency and suitability offer consumers varied entry points to personalisation

Mass-orientated products are deepening segmentations by age, gender, race/ethnicity and hair and skin types, and personalisation only deepens the range of possibilities, with ample opportunities to attract consumers across a range of traits and ethical considerations.

Segmented offerings will stretch personalisation from mass to premium

As personalisation moves closer to the mainstream, greater distance will be placed across the spectrum of these products, with basic segmentation and simple diagnostics available to most, with more innovative and sophisticated personalisation approaches such as biologics/genetics in the premium offer.

Acquisitions and investments in personalisation push movement to massification

Recent acquisitions by companies like Bayer and Nestlé and investments by companies like Beiersdorf, L’Oréal and Sanofi allow personalised products to sit closer to mass-orientated portfolios and provide them with greater access to the scale, marketing and R&D that will likely sustain a wider audience moving forward.

Scope
Key findings
2021 growth in beauty and personal care/consumer health expected; personalisation looming
Democratising Personalisation in Health and Beauty
Exploring Personalisation in Health and Beauty
Personalisation in Health and Beauty in-depth
Access to data
Transparency and suitability
Spectrum of solutions
Product and service mix
Democratising Personalisation in Health and Beauty in focus
Companies are meeting the needs of consumers using various strategies
Using algorithms and network effects: Beiersdorf’s O.W.N
Embedding personalisation within social media: LemonBox
Combining personalisation with traditional practices: Vedix
Differentiating through sustainability : Sanofi’s Livvit
DIY personalisation with devices : L’Oréal’s Perso
Acquisitions to create scale and appeal to mass audiences : Persona and Care/Of
Democratising Personalisation in Health and Beauty
Key industry takeaways
Challenges to overcome
Become tomorrow’s next leader
Share:

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page